These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22248356)

  • 1. A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A.
    Martin MP; Zhu JY; Lawrence HR; Pireddu R; Luo Y; Alam R; Ozcan S; Sebti SM; Lawrence NJ; Schönbrunn E
    ACS Chem Biol; 2012 Apr; 7(4):698-706. PubMed ID: 22248356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
    Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Characterization of the Aurora Kinase B "DFG-flip" Using Metadynamics.
    Lakkaniga NR; Balasubramaniam M; Zhang S; Frett B; Li HY
    AAPS J; 2019 Dec; 22(1):14. PubMed ID: 31853739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors.
    Peng YH; Shiao HY; Tu CH; Liu PM; Hsu JT; Amancha PK; Wu JS; Coumar MS; Chen CH; Wang SY; Lin WH; Sun HY; Chao YS; Lyu PC; Hsieh HP; Wu SY
    J Med Chem; 2013 May; 56(10):3889-903. PubMed ID: 23611691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of mitogen-activated protein kinase kinase 1 in the DFG-out conformation.
    Nakae S; Kitamura M; Fujiwara D; Sawa M; Shirai T; Fujii I; Tada T
    Acta Crystallogr F Struct Biol Commun; 2021 Dec; 77(Pt 12):459-464. PubMed ID: 34866601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational study of the "DFG-flip" conformational transition in c-Abl and c-Src tyrosine kinases.
    Meng Y; Lin YL; Roux B
    J Phys Chem B; 2015 Jan; 119(4):1443-56. PubMed ID: 25548962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib.
    Yan M; Wang H; Wang Q; Zhang Z; Zhang C
    Phys Chem Chem Phys; 2016 Apr; 18(15):10367-74. PubMed ID: 27029952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling conformational flexibility of kinases in inactive states.
    Schwarz D; Merget B; Deane C; Fulle S
    Proteins; 2019 Nov; 87(11):943-951. PubMed ID: 31168936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II Inhibitors Targeting CDK2.
    Alexander LT; Möbitz H; Drueckes P; Savitsky P; Fedorov O; Elkins JM; Deane CM; Cowan-Jacob SW; Knapp S
    ACS Chem Biol; 2015 Sep; 10(9):2116-25. PubMed ID: 26158339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
    Vijayan RS; He P; Modi V; Duong-Ly KC; Ma H; Peterson JR; Dunbrack RL; Levy RM
    J Med Chem; 2015 Jan; 58(1):466-79. PubMed ID: 25478866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead Discovery of Type II BRAF V600E Inhibitors Targeting the Structurally Validated DFG-Out Conformation Based upon Selected Fragments.
    Zhang Q; Zhang X; You Q
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design.
    Dodson CA; Kosmopoulou M; Richards MW; Atrash B; Bavetsias V; Blagg J; Bayliss R
    Biochem J; 2010 Mar; 427(1):19-28. PubMed ID: 20067443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations show that conformational selection governs the binding preferences of imatinib for several tyrosine kinases.
    Aleksandrov A; Simonson T
    J Biol Chem; 2010 Apr; 285(18):13807-15. PubMed ID: 20200154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors.
    Messoussi A; Peyronnet L; Feneyrolles C; Chevé G; Bougrin K; Yasri A
    Molecules; 2014 Oct; 19(10):16223-39. PubMed ID: 25310149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity.
    Schröder M; Bullock AN; Fedorov O; Bracher F; Chaikuad A; Knapp S
    J Med Chem; 2020 Sep; 63(18):10224-10234. PubMed ID: 32787076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Conformational Transition Pathways and Hidden Intermediates in DFG-Flip Process of c-Met Kinase Revealed by Metadynamics Simulations.
    Jiang T; Liu Z; Liu W; Chen J; Zheng Z; Duan M
    J Chem Inf Model; 2022 Aug; 62(15):3651-3663. PubMed ID: 35848778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors.
    Xu M; Yu L; Wan B; Yu L; Huang Q
    PLoS One; 2011; 6(7):e22644. PubMed ID: 21818358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors.
    Lawrence HR; Martin MP; Luo Y; Pireddu R; Yang H; Gevariya H; Ozcan S; Zhu JY; Kendig R; Rodriguez M; Elias R; Cheng JQ; Sebti SM; Schonbrunn E; Lawrence NJ
    J Med Chem; 2012 Sep; 55(17):7392-7416. PubMed ID: 22803810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors.
    Modi SJ; Kulkarni VM
    J Biomol Struct Dyn; 2022 Aug; 40(12):5712-5727. PubMed ID: 33459187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-ATP competitive protein kinase inhibitors.
    Garuti L; Roberti M; Bottegoni G
    Curr Med Chem; 2010; 17(25):2804-21. PubMed ID: 20586715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.